Uncemented Reverse Total Shoulder Arthroplasty for Proximal Humerus Fractures
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 15-003218
Sponsor Protocol Number: 15-003218
About this study
The aim of this protocol is to determine clinical, functional, radiographic, and survival outcomes in patients undergoing an uncemented reverse total shoulder arthroplasty for a proximal humerus fracture.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients who underwent a reverse total shoulder arthroplasty for a 3- or 4-part proximal humerus fracture between January 1, 2004 to the present/ Patient record must contain post-operative and follow-up radiological imaging, adequate clinical information.
- Patients ≥ 18 years of age
Exclusion Criteria:
- Patients < 18 years of age
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator John Sperling, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available